News
11-04-2025, 04:48 PM
A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and increased cancer risk, countering early safety concerns. Instead, evidence suggests possible protective effects for certain cancers, supported by metabolic and immune-modulating mechanisms.
More... (https://www.news-medical.net/news/20251104/Do-GLP-1-drugs-cause-cancer-New-review-says-no-may-even-protect.aspx)
More... (https://www.news-medical.net/news/20251104/Do-GLP-1-drugs-cause-cancer-New-review-says-no-may-even-protect.aspx)